Bio-Rad Laboratories | BIO - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 1000K 2026-03
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 803M 100K 2026-06
Bruker USD 1.81B 151.8M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Danaher USD 25.15B 7.59B 2026-06
General Electric Aerospace USD 17.16B 1.02B 2026-06
Illumina USD 1.49B 1000K 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Merck USD 51.08B 4.41B 2026-06
Mettler Toledo International USD 2.04B 116.92M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Quest Diagnostics USD 5.63B 477M 2026-06
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Siemens EUR 41.32B 199M 2026-06
Standard Biotools USD 299K 0 2026-03
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Tosoh JPY 96.02B 11.78B 2026-06
Waters USD 5.09B 129M 2026-06